Table 1. Association of FILIP1L, Beta-catenin, and SLUG expression with clinicopathological characteristics in normal and neoplastic ovarian tissue samples.

	No	FILIP1L		Beta–catenin		SLUG
		Median [IQR]	p value	Median [IQR	p value	Median [IQR]	p value
Diagnostic category
Normal	64	88 [50–142]	< 0.001	54 [30–89]	< 0.001	110 [79–173]	< 0.001
Benign	29	84 [39–140]		66 [34–100]		141 [86–195]
Borderline	50	59 [29–105]		84 [60–128]		131 [68–183]
Cancer	182	50 [13–109]		106 [71–150]		144 [91–183]
Metastatic	46	35 [12–60]		100 [70–131]		224 [162–266]
Age
≤ 50	85	56 [18–123]	0.032	110 [59–149]	0.808	146 [99–180]	0.755
> 50	97	41 [7–85]		99 [74–150]		143 [83–196]
Histological subtype
Serous	123	50 [17–101]	0.914	101 [73–145]	0.531	146 [86–197]	0.647
Others	59	55 [7–119]		110 [64–170]		140 [107–165]
FIGO stage
I/II	48	91 [30–122]	0.007	101 [60–143]	0.535	136 [81–163]	0.102
III/IV	121	41 [11–76]		101 [74–150]		145 [91–199]
Tumor grade
Well + Moderate	78	51 [12–110]	0.916	110 [80–161]	0.144	143 [83–179]	0.589
Poor	91	50 [16–104]		98 [60–143]		140 [91–181]
CA125
≤ 35	24	43 [20–130]	0.238	99 [60–134]	0.632	136 [87–155]	0.290
> 35	154	51 [11–102]		106 [73–151]		145 [91–183]
Chemosensitivity
Sensitive	152	55 [16–113]	0.002	104 [70–150]	0.182	141 [90–182]	0.041
Resistant	12	5.5 [0–27]		136 [89–155]		168 [147–190]

^aCalculated only 169 cases with available information of FIGO stage and tumor grade.

^bCalculated only 178 cases with available information of CA125.

^cCalculated only 163 cases with available information of chemosensitivity.

Protein expression was determined through analysis of an immunohistochemically stained tissue array, as described in the materials and methods section.